| | | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice acceptor variant) | Fanconi anemia complementation group O +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Deletion (frameshift variant +1 more) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +3 more | |
| | | Duplication (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (stop lost +2 more) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Duplication (frameshift variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Duplication (inframe_insertion) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +5 more | |
| | | Single nucleotide variant (nonsense +1 more) | RAD51C-related disorder +6 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (N203D) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC129390903, RAD51C (R212C) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (R212H) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (E218fs) | Microsatellite (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (L225P) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC129390903, RAD51C (E232D) | Single nucleotide variant (missense variant +1 more) | RAD51C-related disorder +4 more | |
| | LOC129390903, RAD51C (S234*) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (K235N) | Single nucleotide variant (missense variant +1 more) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (splice acceptor variant) | Fanconi anemia complementation group O +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | RAD51C-related disorder +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Deletion (intron variant) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |